Siste oppdatering :
19/11/2024
Forskerteamet - Department of Pharmaceutical and Pharmacological Sciences, University of Padua   pdf  
Italia
universitet
Department of Pharmaceutical and Pharmacological Sciences, University of Padua
Padoue
Email
Referanser   Referanser   (1)  
1
Prolonging the stability of cetuximab (Erbitux®) and panitumumab (Vectibix®): An orthogonal assessment of physicochemical, biological and microbiological properties of original opened glass vials and diluted saline preparations.
Carpanese D, Rossi V, Di Paolo V, Quintieri L, Penna Zuccolotto G, Sebellin J, Saran C, Pipitone F, Miolo G, de Diana E et al. (valentina.rossi@iov.veneto.it)
Int J Pharm - 2024 - ; 649: 123643.

Lister   molekyler Studerte   (2)  
kreft narkotika Injeksjon Cetuximab
kreft narkotika Injeksjon Panitumumab

  Mentions Légales